Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Blood|August 15, 1991
Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study GroupT C Merigan, D A Amato, J Balsley, et al.
European Journal of Pharmacology|November 15, 1988
Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8308A T Chiu, D J Carini, A L Johnson, et al.
American Journal of Hypertension|August 1, 1990
Nonpeptide angiotensin II receptor antagonistsP B Timmermans, D J Carini, A T Chiu, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1995
Pharmacology and pharmacokinetics of a novel nonpeptide angiotensin II receptor antagonist--DMP 811P C Wong, S M Huang, R J Ardecky, et al.
Hypertension (Dallas, Tex. : 1979)|November 11, 1991
Angiotensin II receptor antagonists. From discovery to antihypertensive drugsP B Timmermans, D J Carini, A T Chiu, et al.
Blood Vessels|January 11, 1990
Nonpeptide angiotensin II receptor antagonists: a novel class of antihypertensive agentsP B Timmermans, D J Carini, A T Chiu, et al.
American Journal of Hypertension|April 11, 1991
The discovery of a new class of highly specific nonpeptide angiotensin II receptor antagonistsP B Timmermans, D J Carini, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Nonpeptide angiotensin II receptor antagonists. III. Structure-function studiesA T Chiu, J V Duncia, D E McCall, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonisticP C Wong, P E Aldrich, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agentA T Chiu, D E McCall, W A Price, et al.
Pageof 12